IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 989 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: Biochemical and Ultrastructural study
H.N. Mustafa,Sally A. El Awdan,Gehan A. Hegazy
Tissue and Cell.2013;45(5)350
[DOI]
2Effect of combination therapy of melatonin and orlistat on high fat diet induced changes in lipid profiles and liver function parameters in serum of rats
Sivakumar Annamalai,Lavanya Mohanam,D. Alwin,Venkataraman Prabhu
Obesity Medicine.2016;2(5)41
[DOI]
3Bioactive compounds, antioxidant potential, and hepatoprotective activity of sea cucumber (Holothuria atra) against thioacetamide intoxication in rats
Amr Y. Esmat,Mahmoud M. Said,Amel A. Soliman,Khaled S.H. El-Masry,Elham Abdel Badiea
Nutrition.2013;29(1)258
[DOI]
4Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled trial
Mario Reis Alvares-da-Silva,Alexandre de Araujo,Joo Reinhardt Vicenzi,Gabriel Veber da Silva,Fabiana Bazanella Oliveira,Fernando Schacher,Lucas Oliboni,Aline Magnus,Leticia Pinto Kruel,Rita Prieb,Luiz Nelson Teixeira Fernandes
Hepatology Research.2014;44(9)956
[DOI]
5Randomised clinical trial:l-ornithine-l-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS
M. Bai,C. He,Z. Yin,J. Niu,Z. Wang,X. Qi,L. Liu,Z. Yang,W. Guo,J. Tie,W. Bai,J. Xia,H. Cai,J. Wang,K. Wu,D. Fan,G. Han
Alimentary Pharmacology & Therapeutics.2014;40(1)63
[DOI]
6Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
Roger F. Butterworth,Ali Canbay
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2019;29(1)24
[DOI]
7Combined effect of Cromolyn sodium and Chlorpheniramine Maleate in high fat diet induced obesity
Reena Kumari,Renu Kumari,Souravh Bais
Obesity Medicine.2020;18(1)100218
[DOI]
8L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle
Roger F. Butterworth
Canadian Journal of Gastroenterology and Hepatology.2019;2019(1)1
[DOI]
9Attenuation of acute and chronic liver injury by melatonin in rats
Ramadan A. Saad,Mohamed Fath EL-Bab,Abir A. Shalaby
Journal of Taibah University for Science.2013;7(2)88
[DOI]
10Metabolic abnormalities of gastrointestinal mucosa in celiac disease: Anin vitroproton nuclear magnetic resonance spectroscopy study
Uma Sharma,Deepti Upadhyay,Sujeet Mewar,Asha Mishra,Prasenjit Das,Siddhartha Datta Gupta,Sada Nand Dwivedi,Govind K Makharia,Naranamangalam R Jagannathan
Journal of Gastroenterology and Hepatology.2015;30(10)1492
[DOI]
11Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy
Gerald Kircheis,Stefan Lth
Drugs.2019;79(S1)23
[DOI]
12A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma
Azra Memon,Yuliya Pyao,Yerin Jung,Jung Il Lee,Woon Kyu Lee
International Journal of Molecular Sciences.2020;21(15)5461
[DOI]
13Genotoxicity and subchronic oral toxicity of l-ornithine monohydrochloride
Shigeru Ishida,Miko Sarada,Hiroshi Seki,Larry McGirr,Annette Lau,Koji Morishita
Regulatory Toxicology and Pharmacology.2013;67(3)360
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow